Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 2.3 B2.63 B2.28 B2.48 B 9.69 B Research & development ———— — Operating income 169 M401 M249 M-39 M 780 M Non-Operating Income, Total 20 M16 M2 M2 M 40 M Interest expense, net of interest capitalized 86 M85 M82 M81 M 334 M Non-Operating Income, excl. Interest Expenses -66 M-69 M-80 M-79 M -294 M Unusual income/expense ———— — Pretax income 109 M333 M179 M-104 M 517 M Equity in earnings ———— — Taxes 62 M171 M90 M12 M 335 M Non-controlling/minority interest ———— — After tax other income/expense 2 M10 M-15 M-3 M -6 M Net income before discontinued operations 47 M162 M89 M-116 M 182 M Discontinued operations ———— — Net income 47 M162 M89 M-116 M 182 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 47 M162 M89 M-116 M 182 M Basic earnings per share (Basic EPS) 0.130.450.25-0.33 0.5 Diluted earnings per share (Diluted EPS) 0.130.440.24-0.31 0.5 Average basic shares outstanding 361.2 M362.1 M362.7 M362.3 M — Diluted shares outstanding 363.3 M364.8 M365.4 M364.8 M — EBITDA 369 M598 M450 M159 M 1.58 B EBIT 169 M401 M249 M-39 M 780 M Cost of revenue 927 M994 M876 M890 M 3.69 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 200 M197 M201 M198 M 796 M